Know the Basics: Mantle Cell Lymphoma
This infographic explains some of the basics on mantle cell lymphoma, a type of non-Hodgkin lymphoma.
While is a type of blood cancer, there are actually many subtypes of the disease that can be broken into two main categories: Hodgkin lymphoma and non-Hodgkin lymphoma. From there, diseases can be categorized even further out. For example, mantle cell lymphoma is a type of B-cell non-Hodgkin lymphoma.
Current Food and Drug Administration (FDA)-approved treatments for mantle cell lymphoma include:
- Chemotherapy
- Proteasome inhibitors
- Stem cell transplants
- Surveillance
However, new treatments, such as chimeric antigen receptor (CAR)-T cell therapy and immunotherapy, are also being explored in clinical trials, and could eventually become a promising and effective treatment for the disease.
‘Remarkable’ Results from Tecartus in Patients With R/R MCL
January 4th 2024Patients with relapsed/refractory mantle cell lymphoma described by one expert as “older, sicker and more heavily pretreated” than those previously studied experienced impressive responses to treatment with CAR-T cell therapy Tecartus.
Read More
